S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(0.11%) $83.66
Gas
(-3.32%) $1.920
Gold
(0.30%) $2 349.60
Silver
(-0.43%) $27.52
Platinum
(0.42%) $924.40
USD/EUR
(0.32%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.07%) $92.11

Обновления в реальном времени для Meridian Bioscience Inc [VIVO]

Биржа: NASDAQ Сектор: Healthcare Промышленность: Diagnostics & Research
Последнее обновление31 янв. 2023 @ 00:00

0.00% $ 33.97

Live Chart Being Loaded With Signals

Commentary (31 янв. 2023 @ 00:00):
Profile picture for Meridian Bioscience Inc

Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide...

Stats
Объем за сегодня 5.63M
Средний объем 686 607
Рыночная капитализация 1.49B
EPS $0 ( 2023-05-04 )
Last Dividend $0.125 ( 2019-02-01 )
Next Dividend $0 ( N/A )
P/E 21.09
ATR14 $0.299 (0.88%)
Insider Trading
Date Person Action Amount type
2023-01-31 Williams Felicia Sell 10 274 Common Stock
2023-01-31 Williams Felicia Sell 12 000 Stock Option (Right to Buy)
2023-01-31 Williams Felicia Sell 8 740 Stock Option (Right to Buy)
2023-01-31 Williams Felicia Sell 17 205 Stock Option (Right to Buy)
2023-01-31 Williams Felicia Sell 5 796 Stock Option (Right to Buy)
INSIDER POWER
-88.84
Last 100 transactions
Buy: 118 571 | Sell: 1 534 678

Объем Корреляция

Длинно: 0.42 (neutral)
Кратко: 0.51 (weak)
Signal:(71.236) Neutral

Meridian Bioscience Inc Корреляция

10 Самые положительные корреляции
TCAC0.987
TCACU0.946
GLAQ0.82
ENVIU0.819
10 Самые отрицательные корреляции
KRBP-0.99
RICO-0.904
ORTX-0.817

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Meridian Bioscience Inc Корреляция - Валюта/Сырье

The country flag 0.57
( weak )
The country flag 0.60
( weak )
The country flag -0.46
( neutral )
The country flag 0.37
( neutral )
The country flag -0.10
( neutral )
The country flag -0.06
( neutral )

Meridian Bioscience Inc Финансовые показатели

Annual 2022
Выручка: $333.02M
Валовая прибыль: $188.36M (56.56 %)
EPS: $0.960
FY 2022
Выручка: $333.02M
Валовая прибыль: $188.36M (56.56 %)
EPS: $0.960
FY 2021
Выручка: $317.90M
Валовая прибыль: $201.15M (63.27 %)
EPS: $1.650
FY 2020
Выручка: $253.67M
Валовая прибыль: $156.25M (61.60 %)
EPS: $1.080

Financial Reports:

No articles found.

Meridian Bioscience Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Meridian Bioscience Inc Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0.950 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $0.00678 1990-11-29
Last Dividend $0.125 2019-02-01
Next Dividend $0 N/A
Payout Date 2019-02-14
Next Payout Date N/A
# dividends 114 --
Total Paid Out $9.88 --
Avg. Dividend % Per Year 0.00% --
Score 2.53 --
Div. Sustainability Score 0.950
Div.Growth Potential Score 0
Div. Directional Score 0.115 --
Next Divdend (Est)
(2024-07-17)
$0 Estimate 0.00 %
Dividend Stability
0.17 Bad
Dividend Score
2.53
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
1990 $0 0.00%
1991 $0 0.00%
1992 $0 0.00%
1993 $0 0.00%
1994 $0 0.00%
1995 $0 0.00%
1996 $0 0.00%
1997 $0 0.00%
1998 $0 0.00%
1999 $0 0.00%
2000 $0 0.00%
2001 $0 0.00%
2002 $0 0.00%
2003 $0.160 3.50%
2004 $0.178 3.83%
2005 $0.213 2.70%
2006 $0.307 2.09%
2007 $0.434 2.63%
2008 $0.560 1.88%
2009 $0.680 2.60%
2010 $0.760 3.51%
2011 $0.760 3.21%
2012 $0.950 4.98%
2013 $0.570 2.75%
2014 $0.800 3.06%
2015 $0.800 4.88%
2016 $0.800 4.10%
2017 $0.500 2.80%
2018 $0.500 3.47%
2019 $0.125 0.74%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.1971.500-3.93-5.90[0 - 0.5]
returnOnAssetsTTM-0.05281.200-1.760-2.11[0 - 0.3]
returnOnEquityTTM-0.06811.500-1.867-2.80[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM2.560.8002.181.741[1 - 3]
quickRatioTTM1.4720.8006.054.84[0.8 - 2.5]
cashRatioTTM0.9431.5005.878.81[0.2 - 2]
debtRatioTTM0.0682-1.5008.86-10.00[0 - 0.6]
interestCoverageTTM-65.481.000-10.00-10.00[3 - 30]
operatingCashFlowPerShareTTM-0.008252.00-0.00275-0.00550[0 - 30]
freeCashFlowPerShareTTM-0.1482.00-0.0740-0.148[0 - 20]
debtEquityRatioTTM0.0914-1.5009.63-10.00[0 - 2.5]
grossProfitMarginTTM0.5341.0004.434.43[0.2 - 0.8]
operatingProfitMarginTTM-0.1971.000-5.93-5.93[0.1 - 0.6]
cashFlowToDebtRatioTTM-0.01161.000-1.176-1.176[0.2 - 2]
assetTurnoverTTM0.2680.800-1.544-1.235[0.5 - 2]
Total Score0.950

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-61.831.000-6.350[1 - 100]
returnOnEquityTTM-0.06812.50-1.200-2.80[0.1 - 1.5]
freeCashFlowPerShareTTM-0.1482.00-0.0493-0.148[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-0.008252.00-0.00275-0.00550[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM1.5181.5003.220[0.5 - 2]
operatingCashFlowSalesRatioTTM-0.002951.000-2.570[0.1 - 0.5]
Total Score-0.720

Meridian Bioscience Inc

Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare brands; and urea breath testing for H. pylori under the BreathID and BreathTek brand. This segment also offers respiratory illness assays, such as tests Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry products for LeadCare test kits for the detection of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.

О Торговые сигналы

Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.

Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа